Literature DB >> 29171450

Treatment outcome of tuberculosis patients under directly observed treatment short course and its determinants in Shangla, Khyber-Pakhtunkhwa, Pakistan: A retrospective study.

Tauseef Ahmad1, Muhammad Khan2, Muhammad Mumtaz Khan3, Eyasu Ejeta4, Manoochehr Karami5, Chinenyenwa Ohia6.   

Abstract

BACKGROUND: Tuberculosis (TB) is one of the leading causes of morbidity and mortality in Pakistan. Assessment of TB treatment outcomes, monitoring and evaluation of its risk factors in Directly Observed Treatment Short Course (DOTS) are among the major indicators of the performance of a national TB control program. Even though Pakistan ranks 5th among the 22 high-TB burden countries, there are no available data in this regard.
METHODS: Institution-based retrospective study was conducted to determine the treatment outcome of TB patients and investigate associated risk factors at District Head Quarter Hospital Shangla, Khyber-Pakhtunkhwa, Pakistan. Two-year record (January 2011 to December 2012) of TB clinic of the hospital was reviewed. A total of 493 patients' complete information was reviewed in the study period.
RESULTS: Of these, 42.19% were smear-positive pulmonary TB (PTB), 35.09% were smear-negative PTB, and 22.72% were extra-PTB (EPTB). The overall prevalence of smear-positive PTB was 42.19% (95% confidence interval [CI]: 37.9-46.2). Records of the treatment outcome showed that 192 (38.94%) were cured, 276 (55.98%) completed treatment, 13 (2.6%) defaulted, 9 (1.8%) died, 1 (0.2%) treatment failure, and 1 (0.2%) had transferred to other facilities. The overall mean treatment success rate of the TB patients was 94.93%. TB age and TB form or baseline smear were significantly associated with unsuccessful treatment outcome. The risk of unsuccessful outcome was significantly lower among TB patients age
Conclusion: The treatment success rate was high and match the World Health Organization criteria. To sustain the effective implementation of DOTS in the area, effective management, and diagnosis should be given for EPTB.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29171450     DOI: 10.4103/ijmy.ijmy_69_17

Source DB:  PubMed          Journal:  Int J Mycobacteriol        ISSN: 2212-5531


  7 in total

1.  Treatment outcomes of extrapulmonary tuberculosis in Bahawalpur, Pakistan; a record review.

Authors:  Muhammad Atif; Razia Fatima; Nafees Ahmad; Zaheer-Ud-Din Babar
Journal:  J Pharm Policy Pract       Date:  2020-07-24

2.  Treatment outcomes of patients with tuberculosis in war affected region of Khyber Pakhtunkhwa, Pakistan.

Authors:  Tauseef Ahmad; Muhammad Ayub Jadoon; Muhammad Khan; Muhammad Mumtaz Khan; Akbar Hussain; Taha Hussein Musa; Muhammad Waqar; Eyasu Ejeta; Manoochehr Karami; Kefyalew Addis Alene; Hui Jin
Journal:  BMC Infect Dis       Date:  2020-07-01       Impact factor: 3.090

3.  Treatment Outcomes and Predictors Among Tuberculosis Patients at Madda Walabu University Goba Referral Hospital, Southeast Ethiopia.

Authors:  Ayele Mamo; Mohammedaman Mama; Damtew Solomon; Mesud Mohammed
Journal:  Infect Drug Resist       Date:  2021-01-05       Impact factor: 4.003

4.  Susceptibility pattern of Mycobacterium tuberculosis over a period of five years at Indus Hospital and Health Network, Karachi, Pakistan.

Authors:  Nazia Khursheed; Sunil Asif; Safia Bano; Maria Mushtaq Ali; Fareeha Adnan
Journal:  Pak J Med Sci       Date:  2022-01       Impact factor: 1.088

5.  Factors associated with hospitalization and death among TB/HIV co-infected persons in Porto Alegre, Brazil.

Authors:  Maíra Rossetto; Évelin Maria Brand; Renata Mendonça Rodrigues; Laura Serrant; Luciana Barcellos Teixeira
Journal:  PLoS One       Date:  2019-01-02       Impact factor: 3.240

6.  Factors predictive of the success of tuberculosis treatment: A systematic review with meta-analysis.

Authors:  Ninfa Marlen Chaves Torres; Jecxy Julieth Quijano Rodríguez; Pablo Sebastián Porras Andrade; María Belen Arriaga; Eduardo Martins Netto
Journal:  PLoS One       Date:  2019-12-27       Impact factor: 3.240

7.  Understanding how geographic, demographic and treatment history impact health outcomes of patients with multi-drug-resistant tuberculosis in Pakistan, 2014-2017.

Authors:  F Iqbal; M K Defer; A Latif; H Hadi
Journal:  Epidemiol Infect       Date:  2020-09-30       Impact factor: 2.451

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.